Treatment-related leukemia

Charles A. Coltman, Steve Dahlberg

Research output: Contribution to journalEditorialpeer-review

26 Scopus citations

Abstract

The majority of the published studies addressing the question of treatment-related leukemia used cohort methods of analysis in which the incidence of leukemia was measured among patients treated for primary cancer. Comparisons of the risk of leukemia have been made between patients and age- and sex-matched populations or between subsets of patients treated with different regimens. There may be bias associated with these methods,1 in that patients with Hodgkin's disease, for example, may differ from the “normal” population with respect to the risk of leukemia. The differences could include the more careful follow-up of patients with Hodgkin's disease, or more …

Original languageEnglish (US)
Pages (from-to)52-53
Number of pages2
JournalNew England Journal of Medicine
Volume322
Issue number1
DOIs
StatePublished - Jan 4 1990
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Treatment-related leukemia'. Together they form a unique fingerprint.

Cite this